Abstract:Background: Among head and neck squamous cell carcinomas (HNSCCs), hypopharyngeal squamous cell carcinoma (HPSCC) has the worst prognosis. Iron metabolism, which plays a crucial role in tumor progression, is mainly regulated by alterations to genes and post-transcriptional processes. The recent discovery of the N6-methyladenosine (m(6)A) modification has expanded the realm of previously undiscovered post-transcriptional gene regulation mechanisms in eukaryotes. Many studies have demonstrated that m(6)A methylation represents a distinct layer of epigenetic deregulation in carcinogenesis and tumor proliferation. However, the status of m(6)A modification and iron metabolism in HPSCC remains unknown. Methods: Bioinformatics analysis, sample analysis, and transcriptome sequencing were performed to evaluate the correlation between m(6)A modification and iron metabolism. Iron metabolic and cell biological analyses were conducted to evaluate the effect of the m(6)A reader YTHDF1 on HPSCC proliferation and iron metabolism. Transcriptome-wide m(6)A-seq and RIP-seq data were mapped to explore the molecular mechanism of YTHDF1 function in HPSCC. Results: YTHDF1 was found to be closely associated with ferritin levels and intratumoral iron concentrations in HPSCC patients at Sir Run Run Shaw Hospital. YTHDF1 induced-HPSCC tumorigenesis depends on iron metabolism in vivo in vitro. Mechanistically, YTHDF1 methyltransferase domain interacts with the 3'UTR and 5'UTR of TRFC mRNA, then further positively regulates translation of m(6)A-modified TFRC mRNA. Gain-of-function and loss-of-function analyses validated the finding showing that TFRC is a crucial target gene for YTHDF1-mediated increases in iron metabolism. Conclusion: YTHDF1 enhanced TFRC expression in HPSCC through an m(6)A-dependent mechanism. From a therapeutic perspective, targeting YTHDF1 and TFRC-mediated iron metabolism may be a promising strategy for HPSCC.

Methionine deficiency facilitates antitumour immunity by altering m6A methylation of immune checkpoint transcripts

Single-cell N6-methyladenosine Regulator Patterns Guide Intercellular Communication of Tumor Microenvironment That Contribute to Colorectal Cancer Progression and Immunotherapy

Effects of RNA Methylation N6-methyladenosine Regulators on Malignant Progression and Prognosis of Melanoma.

Methionine restriction-induced sulfur deficiency impairs antitumour immunity partially through gut microbiota

Dietary methionine restriction in cancer development and antitumor immunity

Cancer SLC43A2 alters T cell methionine metabolism and histone methylation

Dietary methionine restriction impairs anti-tumor immunity through gut microbiota

Dietary Methionine Influences Therapy in Mouse Cancer Models and Alters Human Metabolism

Intermittent dietary methionine deprivation facilitates tumoral ferroptosis and synergizes with checkpoint blockade

Methionine cycle-dependent regulation of T cells in cancer immunity

YTHDF1-enhanced iron metabolism depends on TFRC m 6 A methylation.

YTHDF2 Upregulation and Subcellular Localization Dictate CD8 T Cell Polyfunctionality in Anti-Tumor Immunity

RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming

YTHDF2 upregulation and relocation dictate CD8 T cell polyfunctionality in tumor immunity

Dietary methionine restriction targets one carbon metabolism in humans and produces broad therapeutic responses in cancer

Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation

The role of RNA methylation in tumor immunity and its potential in immunotherapy

METTL3-mediated m6A RNA methylation promotes the anti-tumour immunity of natural killer cells

The tumor-intrinsic role of the m 6 A reader YTHDF2 in regulating immune evasion

Methionine Metabolism in Health and Cancer: a Nexus of Diet and Precision Medicine

The role of histone methylase and demethylase in antitumor immunity: A new direction for immunotherapy